In addition, the conolidine molecule didn't connect with the classical receptors, which means that it would not compete from opioid peptides to bind to these receptors.In 2011, the Bohn lab noted antinociception from the two chemically induced and inflammation-derived discomfort, and experiments indicated deficiency of opioid receptor modulation, b